Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436 CH)
Watchlist
86
Analysis
Health Care
•
China
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. manufactures and markets Chinese traditional medicines, including Pientzehuang, Pientzehuang capsules, Pientzehuang lozenge, cough syrup, and other related products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
•
12 May 2024 16:12
China Healthcare Weekly (May12)-Policy Catalyst in Medical Device, GLP-1 Overvaluation, Pientzehuang
New policy catalysts in medical device sector arrives.Current valuation of weight-loss drug companies have “big bubble”.Due to China's de...
Xinyao (Criss) Wang
Follow
332 Views
Share
bearish
•
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
•
31 Jan 2024 08:55
Zhangzhou Pientzehuang Pharmaceutical (600436.CH) 2023 Results - Get Ready for More Downside Ahead
China's de-financialization process would change the investment logic of companies/products with strong financial attributes.Their growth potential...
Xinyao (Criss) Wang
Follow
291 Views
Share
bullish
•
Cambricon Technologies Lt
•
17 Jul 2024 06:30
SSE50 Index Rebalance Preview: Potential Inclusions Outperforming (And How!)
There could be 4-5 changes in Dec. Estimate one-way turnover is 6.5% leading to a one-way trade of CNY 8.8bn (US$1.2bn). The potential adds have...
Brian Freitas
Follow
235 Views
Share
bullish
•
Beijing-Shanghai High Speed Ra
•
15 Jul 2024 19:12
Quiddity Leaderboard SSE50/180 Dec 24: US$1.6bn+ One-Way; Some Changes to Expectations.
There could be US$1.4bn and US$240mn one-way flows, respectively, for the SSE 50 and SSE 180 December 2024 rebalances. Around 70% of the reference...
Janaghan Jeyakumar, CFA
Follow
220 Views
Share
bearish
•
China Resources Medical
•
30 Jun 2024 15:56
China Healthcare Weekly (Jun.30) - TCM Companies Witness Soaring Costs, Rising Stars in ADC, 1515.HK
Investors should watch for rising TCM raw material prices. Chinese pharmaceutical companies are rising in ADC.Caution with China Resources...
Xinyao (Criss) Wang
Follow
354 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x